# Eagle Bancorp Montana, Inc.: financial statements, quarterly

EBMT · Nasdaq · CIK 1478454 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ebmt.md) · [Financials](/companies/ebmt/financials.md) · [Filings](/companies/ebmt/filings.md) · [Insiders](/companies/ebmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ebmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [8,507](/filings/0001437749-23-031142.md) | [9,343 d](/filings/0001437749-24-006812.md) | [9,728](/filings/0001437749-24-015286.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [524](/filings/0001437749-24-034837.md) | [(315) d](/filings/0001437749-25-007739.md) | [370](/filings/0001437749-25-015368.md) | [444](/filings/0001437749-25-025323.md) | [529](/filings/0001437749-25-033182.md) | [269 d](/filings/0001437749-26-007330.md) | [631](/filings/0001437749-26-015453.md) | [751](/filings/0001437749-26-025842.md) | [1,326](/filings/0001437749-25-033182.md) | [1,350 d](/filings/0001437749-26-007330.md) | [1,110](/filings/0001437749-26-015453.md) | [1,105](/filings/0001437749-26-025842.md) |
| Net income | $k | [2,635](/filings/0001437749-24-034837.md) | [2,164 d](/filings/0001437749-25-007739.md) | [1,898](/filings/0001437749-25-015368.md) | [1,738](/filings/0001437749-25-025323.md) | [2,709](/filings/0001437749-25-033182.md) | [3,433 d](/filings/0001437749-26-007330.md) | [3,239](/filings/0001437749-26-015453.md) | [3,237](/filings/0001437749-26-025842.md) | [3,630](/filings/0001437749-25-033182.md) | [4,729 d](/filings/0001437749-26-007330.md) | [3,984](/filings/0001437749-26-015453.md) | [3,715](/filings/0001437749-26-025842.md) |
| Diluted EPS | $ per share | [0.34](/filings/0001437749-24-034837.md) | not reported | [0.24](/filings/0001437749-25-015368.md) | [0.22](/filings/0001437749-25-025323.md) | [0.34](/filings/0001437749-25-033182.md) | not reported | [0.41](/filings/0001437749-26-015453.md) | [0.41](/filings/0001437749-26-025842.md) | [0.46](/filings/0001437749-25-033182.md) | not reported | [0.51](/filings/0001437749-26-015453.md) | [0.47](/filings/0001437749-26-025842.md) |
| Basic EPS | $ per share | [0.34](/filings/0001437749-24-034837.md) | not reported | [0.24](/filings/0001437749-25-015368.md) | [0.22](/filings/0001437749-25-025323.md) | [0.35](/filings/0001437749-25-033182.md) | not reported | [0.41](/filings/0001437749-26-015453.md) | [0.42](/filings/0001437749-26-025842.md) | [0.47](/filings/0001437749-25-033182.md) | not reported | [0.51](/filings/0001437749-26-015453.md) | [0.47](/filings/0001437749-26-025842.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.8](/filings/0001437749-23-031142.md) | [24.5](/filings/0001437749-25-007739.md) | [20.9](/filings/0001437749-24-015286.md) | [23.8](/filings/0001437749-24-025408.md) | [42.2](/filings/0001437749-24-034837.md) | [31.6](/filings/0001437749-26-007330.md) | [22.8](/filings/0001437749-25-015368.md) | [26.9](/filings/0001437749-25-025323.md) | [29.5](/filings/0001437749-25-033182.md) | [63.0](/filings/0001437749-26-025842.md) | [53.7](/filings/0001437749-26-015453.md) | [29.0](/filings/0001437749-26-025842.md) |
| Total assets | $m | [2,063](/filings/0001437749-23-031142.md) | [2,076](/filings/0001437749-25-007739.md) | [2,076](/filings/0001437749-24-015286.md) | [2,099](/filings/0001437749-24-025408.md) | [2,145](/filings/0001437749-24-034837.md) | [2,103](/filings/0001437749-26-007330.md) | [2,088](/filings/0001437749-25-015368.md) | [2,138](/filings/0001437749-25-025323.md) | [2,120](/filings/0001437749-25-033182.md) | [2,106](/filings/0001437749-26-025842.md) | [2,092](/filings/0001437749-26-015453.md) | [2,126](/filings/0001437749-26-025842.md) |
| Total liabilities | $m | [1,906](/filings/0001437749-23-031142.md) | [1,906](/filings/0001437749-25-007739.md) | [1,907](/filings/0001437749-24-015286.md) | [1,929](/filings/0001437749-24-025408.md) | [1,967](/filings/0001437749-24-034837.md) | [1,928](/filings/0001437749-26-007330.md) | [1,911](/filings/0001437749-25-015368.md) | [1,957](/filings/0001437749-25-025323.md) | [1,933](/filings/0001437749-25-033182.md) | [1,915](/filings/0001437749-26-025842.md) | [1,899](/filings/0001437749-26-015453.md) | [1,928](/filings/0001437749-26-025842.md) |
| Long-term debt | $m | [59.0](/filings/0001437749-23-031142.md) | [59.0](/filings/0001437749-25-007739.md) | [59.0](/filings/0001437749-24-015286.md) | [59.1](/filings/0001437749-24-025408.md) | [59.1](/filings/0001437749-24-034837.md) | [59.1](/filings/0001437749-26-007330.md) | [59.2](/filings/0001437749-25-015368.md) | [59.2](/filings/0001437749-25-025323.md) | [59.3](/filings/0001437749-25-033182.md) | [44.5](/filings/0001437749-26-025842.md) | [44.5](/filings/0001437749-26-015453.md) | [44.5](/filings/0001437749-26-025842.md) |
| Shareholders' equity | $m | [157](/filings/0001437749-24-034837.md) | [169](/filings/0001437749-26-007330.md) | [169](/filings/0001437749-25-025323.md) | [170](/filings/0001437749-25-033182.md) | [178](/filings/0001437749-25-033182.md) | [175](/filings/0001437749-26-025842.md) | [178](/filings/0001437749-26-025842.md) | [181](/filings/0001437749-26-025842.md) | [186](/filings/0001437749-25-033182.md) | [192](/filings/0001437749-26-025842.md) | [193](/filings/0001437749-26-025842.md) | [197](/filings/0001437749-26-025842.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.2 d](/filings/0001437749-24-034837.md) | [12.2 d](/filings/0001437749-25-007739.md) | [7.1](/filings/0001437749-25-015368.md) | [3.3 d](/filings/0001437749-25-025323.md) | [2.6 d](/filings/0001437749-25-033182.md) | [15.6 d](/filings/0001437749-26-007330.md) | [1.9](/filings/0001437749-26-015453.md) | [1.7 d](/filings/0001437749-26-025842.md) | [9.0 d](/filings/0001437749-25-033182.md) | [20.5 d](/filings/0001437749-26-007330.md) | [(4.7)](/filings/0001437749-26-015453.md) | [(2.1) d](/filings/0001437749-26-025842.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001437749-24-034837.md) | [2.6 d](/filings/0001437749-25-007739.md) | [4.8](/filings/0001437749-25-015368.md) | [2.6 d](/filings/0001437749-25-025323.md) | [3.3 d](/filings/0001437749-25-033182.md) | [3.3 d](/filings/0001437749-26-007330.md) | [1.6](/filings/0001437749-26-015453.md) | [0.4 d](/filings/0001437749-26-025842.md) | [1.9 d](/filings/0001437749-25-033182.md) | [0.9 d](/filings/0001437749-26-007330.md) | [0.5](/filings/0001437749-26-015453.md) | [0.7 d](/filings/0001437749-26-025842.md) |
| Dividends paid | $m | [1.1 d](/filings/0001437749-24-034837.md) | [1.1 d](/filings/0001437749-25-007739.md) | [1.1](/filings/0001437749-25-015368.md) | [1.1 d](/filings/0001437749-25-025323.md) | [1.1 d](/filings/0001437749-25-033182.md) | [1.1 d](/filings/0001437749-26-007330.md) | [1.1](/filings/0001437749-26-015453.md) | [1.1 d](/filings/0001437749-26-025842.md) | [1.2 d](/filings/0001437749-25-033182.md) | [1.2 d](/filings/0001437749-26-007330.md) | [1.2](/filings/0001437749-26-015453.md) | [1.2 d](/filings/0001437749-26-025842.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-034837.md) | [0.0 d](/filings/0001437749-25-007739.md) | [0.0](/filings/0001437749-25-015368.md) | [0.0 d](/filings/0001437749-25-025323.md) | [0.0 d](/filings/0001437749-25-033182.md) | [0.4 d](/filings/0001437749-26-007330.md) | [0.8](/filings/0001437749-26-015453.md) | [0.4 d](/filings/0001437749-26-025842.md) | [0.0 d](/filings/0001437749-25-033182.md) | [0.4 d](/filings/0001437749-26-007330.md) | [0.0](/filings/0001437749-26-015453.md) | [0.0 d](/filings/0001437749-26-025842.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,808](/filings/0001437749-23-031142.md) | [7,792](/filings/0001437749-24-015286.md) | [7,793](/filings/0001437749-24-025408.md) | [7,792](/filings/0001437749-24-034837.md) | [7,835](/filings/0001437749-25-015368.md) | [7,845](/filings/0001437749-25-025323.md) | [7,860](/filings/0001437749-25-033182.md) | [7,824](/filings/0001437749-26-015453.md) | [7,813](/filings/0001437749-26-025842.md) | [7,829](/filings/0001437749-25-033182.md) | [7,844](/filings/0001437749-26-015453.md) | [7,862](/filings/0001437749-26-025842.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,965,431 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001437749-26-025842.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.